The Quiet Retreat
Regional dental DSOs – the mid-sized dental service organizations that spent the better part of a decade buying up independent practices – are now doing something far less publicized: selling them back off, closing them down, or transferring them to smaller operators who will take them at a discount.
Why the Expansion Math Stopped Working
The growth model that defined regional DSO strategy through the late 2010s and early 2020s was built on a specific set of assumptions: that adding locations increased purchasing power, that centralized billing and HR would compress overhead, and that a larger footprint made the whole organization more attractive to private equity. Those assumptions held well enough when interest rates were low and capital was cheap. They are considerably harder to defend now.
The problem with clinic-level economics in dentistry is that patient volume is intensely local. A practice in a suburb that’s losing population, or one that sits inside a commercial corridor that’s shifted away from foot traffic, can’t be fixed by better centralized management. The patients simply aren’t there, or they’ve moved to a competing practice closer to where they now live or work. Regional DSOs, unlike their national counterparts, often lack the geographic diversification to absorb several underperformers simultaneously without feeling real pressure on overall margins.
Staffing has compounded the issue. Dental hygienists and associates have had meaningful leverage in the labor market, and regional DSOs – without the brand recognition of a national chain or the partnership equity of a solo-owned practice – have found it harder to retain clinical staff at the locations that were already struggling. A clinic that cycles through hygienists every few months loses patient relationships, and patient relationships in dentistry are sticky in both directions: hard to build, easy to lose.
Then there’s the debt structure. Many regional DSOs used acquisition financing that made sense under a specific growth timeline. When that timeline slips – because integration took longer, because a new location never hit its patient volume targets, because a key associate dentist left – the carrying cost of underperforming locations starts to look very different on a consolidated balance sheet. The offloading happening now isn’t panic selling in most cases. It’s portfolio management under pressure, done quietly because no organization wants to advertise that its expansion strategy had holes in it.
How the Offloading Actually Works
The transactions rarely look like formal divestitures. A regional DSO with fifteen locations doesn’t hold a press conference to announce it’s closing three of them. More often, a struggling location gets transferred to a dentist-operator who’s willing to take on the lease and patient files in exchange for reduced buy-in terms. The DSO exits a fixed cost, the incoming operator gets a patient base without paying full market value for a healthy practice, and the whole thing is structured as a management transition rather than a sale. Both sides have reasons to keep it quiet.
In other cases, the location simply closes – a harder outcome for both the organization and the patients. When a clinic shuts, active patients get a notice, records get transferred, and the DSO absorbs whatever lease obligations remain. This happens more often in markets where the patient volume was never strong enough to attract a buyer willing to take over operations. Rural and exurban locations that DSOs acquired during the aggressive expansion phase have proven particularly difficult to offload because the economics that made them unattractive to the DSO make them unattractive to individual buyers as well.
A third path involves selling to a smaller regional competitor or to a solo practitioner who wants to expand without building from scratch. This is arguably the most functional outcome: the practice continues operating, patients don’t lose their provider, and the DSO recovers some value from an asset that was dragging on its financials. The price in these deals tends to be well below what the DSO originally paid for the location, particularly if the practice’s collections have declined or if the facility needs capital investment the DSO wasn’t making.
The pattern bears some resemblance to what’s unfolding in regional physical therapy networks, where the same private-equity-fueled growth cycle is producing a similar reckoning with locations that never hit their pro forma numbers. In both sectors, the organizations doing the selling are careful to frame exits as strategic portfolio optimization rather than retreat – the language of board decks, not operational failure.
What’s notable is how little of this shows up in public filings or trade press. Regional DSOs are not publicly traded entities for the most part, so there’s no disclosure obligation. The transactions live in local real estate records, state dental board ownership filings, and the institutional memory of practice brokers who handle the deals. For patients, the first sign that something has changed is often a notice letter or, worse, a closed door.
What Comes Next for These Locations
The locations being offloaded right now will find different fates depending on their market. In areas with genuine dental access gaps, a closed DSO clinic represents a real problem – not just an abstract consolidation story. Independent dentists considering those locations face the same underlying economics that made them unworkable for the DSO, plus the added cost of establishing a brand and patient base from near zero. Some will succeed. Others will sit vacant long enough that the patient population fully disperses to other providers.
For the DSOs that survive the current pruning, the question is whether the remaining locations are actually healthy or simply less sick. A regional organization that sheds four underperformers and retains twelve profitable ones has improved its balance sheet on paper, but it has also revealed something about the limits of its original acquisition strategy. The practices that got bought at peak multiples and never performed to expectation don’t disappear from the story just because they’ve been transferred or closed – they show up in the write-downs, in the renegotiated debt terms, and in the credibility gap the next time the same organization tries to raise capital for expansion.
